Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
K-RAS MUTATIONS AND ANTI-EGFR ANTIBODY THERAPY

No-Receipt date 2022-00984 - 15/03/2022
No-Filing date 20220400590 - 15/03/2022
No-Granting date 3083232.B2 - 23/03/2022
No-EPO application date 08742061.8 - 11/03/2008
No-EPO granting date 2121989 - 09/03/2022
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 3/2022 - 18/04/2022
Expiration date 12/03/2028
Kind of title Amended European Patent Validation
Legal status VALID
Priorities US906943 P13/03/2007/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
G01N 33/574
C12Q 1/68

Related Documents

Related Titles
TypeMaster titleRelated title
[ADD] 20140400753

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1411029 AMGEN INC. ONE AMGEN CENTER DRIVETHOUSAND OAKS, CA 91320-1799 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
3636728 FREEMAN, DANIEL
3636729 JUAN, TODD
3636730 RADINSKY, ROBERT

Representatives
CodeFirstnameSurnameAddressTownZip
3178STEFANOS ALEXIOSTSIMIKALIS "TSIMIKALIS KALONAROU DIKIGORIKI ETAIREIA"NEOFYTOU VAMVA 1ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
8126STEFANOS ALEXIOSTSIMIKALISNEOFYTOU VAMVA 1ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments

Payments history 19 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015